JIC
CTSO icon

Johnson Investment Counsel’s Cytosorbents Corp CTSO Stock Holding History

Johnson Investment Counsel’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,534
Closed -$10.5K – 811
2024
Q4 		$10.5K Sell
11,534
-1,272
-10% -$1.25K ﹤0.01% 787
2024
Q3 		$19.2K Sell
12,806
-4,628
-27% -$5.08K ﹤0.01% 803
2024
Q2 		$12.3K Sell
17,434
-1,953
-10% -$1.69K ﹤0.01% 763
2024
Q1 		$18.4K Sell
19,387
-584
-3% -$568 ﹤0.01% 757
2023
Q4 		$22.2K Buy
+19,971
New +$29.7K ﹤0.01% 709

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson Investment Counsel's CTSO Position: Q1 2025 in Review

Johnson Investment Counsel sold out of Cytosorbents Corp (CTSO) in Q1 2025, closing a stake of 11,534 shares — an estimated $10.5K sold.

Johnson Investment Counsel first reported a position in CTSO in Q4 2023 and held it in 5 quarters. The position peaked at $22.2K in Q4 2023. 49 funds tracked by Wall St. Rank hold CTSO as of Q1 2025.

  • Johnson Investment Counsel reported no remaining Cytosorbents Corp position as of Q1 2025 after selling out during the quarter.
  • Johnson Investment Counsel sold 11,534 Cytosorbents Corp shares in Q1 2025, an estimated $10.5K.
  • Johnson Investment Counsel first reported a position in Cytosorbents Corp in Q4 2023 and held it in 5 quarters.
  • Johnson Investment Counsel's Cytosorbents Corp position peaked at $22.2K in Q4 2023.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2025.

Based on Johnson Investment Counsel's 13F filing for Q1 2025, filed 21 Apr 2025.